Smart science to improve lives™
Pharma

Explore our newest products

We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications. 

Find out more information on our newest products:

squalene image with blue wash over image

Sustainably sourced Squalene

Introducing our sustainably sourced Squalene, produced using cutting-edge technology that centres on synthetic biology, our pharmaceutical-grade squalene has superior purity and carries the same squalene benefits as shark-derived squalene.

Vaccine shown over map image

Sustainable saponins (2024)

As we look to become more nature positive, we’re proud to be able to offer our next-generation QS 21 and support global sustainability efforts. Our next-generation QS 21 is based on plant tissue culture, which makes the process more efficient and sustainably sourced.

Woman in lab looking at tray with purple wash over image

Introducing Virodex™

We’re introducing our new range of detergents specifically designed to support the key steps in your biomanufacturing processes. The Virodex™ range for viral inactivation and cell lysis is REACH-compliant, compendial, sustainable, and has been optimised for use in biomanufacturing of recombinant proteins, blood fractionation products, viral vectors, and more.

How we empower biologics delivery

Image of Croda Pharma innovating in a lab

Enabling breakthrough innovation

Dedicated to developing the next generation of excipients and delivery systems to empower biopharma
Female Croda Pharma employee formulating in lab

Access to specialist formulation support

Enabling over 250 on-going clinical projects targeting a range of therapeutic areas across biologics and small molecules
Croda Pharma employee in a lab

Focused scientific expertise

Leading the way with specialist knowledge and synthesis expertise in excipients, adjuvants and lipids

Explore recent blogs:

Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards

Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...

Read more
lab image

Partnership agreement between Croda and AAHI to drive innovation in vaccine development

19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...

Read more
child being vaccinated

Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.

Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.

Read more

Product Spotlight - Super Refined PEG 400

Super Refined PEG 400 is a highly purified solubiliser is an exemplary excipient in both small molecule and protein formulations containing the most sensitive APIs for treatments of a range of...

Read more